41 results
Page 2 of 3
6-K
tgv3 5biyqwn5bk
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
ahcc3 b4otqkjv1ikz1
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.2
k1ffdhjgjpjc7ae hsga
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-99.1
mg7ka qlzvqqf
24 Oct 16
Bioblast Announces Results of Trehalose Clinical Study
12:00am
424B5
suya029l
18 Mar 16
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
aqljb1
27 Oct 15
Current report (foreign)
12:00am
6-K
EX-99.2
e4njh3x
27 Oct 15
Current report (foreign)
12:00am
20-F
w3t9d1yksqy3
31 Mar 15
Annual report (foreign)
12:00am
6-K
EX-99.1
ojc9jhho8frqk7xstati
10 Feb 15
Notice of Extraordinary General Meeting of Shareholders
12:00am
6-K
EX-99.1
mc3y meh1k5q3i
8 Jan 15
Current report (foreign)
12:00am
6-K
EX-99.1
5lkuopfxfzo3ly
22 Sep 14
Bio Blast Pharma Announces Initiation of its Canadian OPMD Clinical Study Center at McGill University, Montreal
12:00am
6-K
EX-99.1
fu9if4k1b
17 Sep 14
BioBlast Pharma Announces Preclinical and Clinical Pharmacokinetic Results with Cabaletta, Interim Safety Results from Phase 2/3HOPEMD Study in OPMD
12:00am
424B4
b2rkb oujdsqvj
31 Jul 14
Prospectus supplement with pricing info
12:00am